A Trial of SHR-7367 in Subjects With Advanced Solid Tumors

Clinical trial NCT05740202 · COMPLETED

Trial details

NCT number: NCT05740202
Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2023-03-06
Primary completion: 2025-08-04
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.